Katharine E. Spink
2016
In 2016, Katharine E. Spink earned a total compensation of $879K as Vice President and Chief Operating Officer at Asterias Biotherapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Option Awards | $396,676 |
|---|---|
| Salary | $314,100 |
| Stock Awards | $155,224 |
| Other | $13,027 |
| Total | $879,027 |
Spink received $396.7K in option awards, accounting for 45% of the total pay in 2016.
Spink also received $314.1K in salary, $155.2K in stock awards and $13K in other compensation.
Rankings
In 2016, Katharine E. Spink's compensation ranked 8,846th out of 14,075 executives tracked by ExecPay. In other words, Spink earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,846 out of 14,075 | 37th |
Division Manufacturing | 3,421 out of 5,486 | 38th |
Major group Chemicals And Allied Products | 1,159 out of 1,900 | 39th |
Industry group Drugs | 912 out of 1,543 | 41st |
Industry Biological Products, Except Diagnostic Substances | 157 out of 287 | 45th |
Source: SEC filing on May 1, 2017.
Spink's colleagues
We found three more compensation records of executives who worked with Katharine E. Spink at Asterias Biotherapeutics in 2016.